These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Collaborative research presents special problems for patent seekers. Thorne LW; Ergenzinger ER; Spruill WM Nat Biotechnol; 2004 Jul; 22(7):901-2. PubMed ID: 15229550 [No Abstract] [Full Text] [Related]
4. Patent issues in drug development: perspectives of a pharmaceutical scientist-attorney. Melethil S AAPS J; 2005 Oct; 7(3):E723-8. PubMed ID: 16353948 [TBL] [Abstract][Full Text] [Related]
5. Research tool patents: tips for facing a "pay up now or litigate" ultimatum. Gogoris A; Ancona P Nat Biotechnol; 2001 Nov; 19(11):1075-7. PubMed ID: 11689855 [No Abstract] [Full Text] [Related]
6. First round to Amgen in EPO battle. Robertson D Nat Biotechnol; 2000 May; 18(5):483. PubMed ID: 10802602 [No Abstract] [Full Text] [Related]
7. Enzo Biochem v. Gen-Probe: complying with the written description requirement under US patent law. Blaug S; Shuster M; Su H Nat Biotechnol; 2003 Jan; 21(1):97-9. PubMed ID: 12511910 [No Abstract] [Full Text] [Related]
8. Will pharmacogenomics alter the role of patents in drug development? Eisenberg RS Pharmacogenomics; 2002 Sep; 3(5):571-4. PubMed ID: 12223043 [No Abstract] [Full Text] [Related]
9. Patent protection. Canadian drug firms boost R&D spending. Spurgeon D Nature; 1992 Feb; 355(6362):666. PubMed ID: 1741046 [No Abstract] [Full Text] [Related]
10. Pharmacia pilots patent share for HIV drug. Nat Rev Drug Discov; 2003 Apr; 2(4):254. PubMed ID: 12680360 [No Abstract] [Full Text] [Related]
11. 3D Printing in Drug Delivery Formulation: You Can Dream it, Design it and Print it. How About Patent it? Pillay V; Choonara YE Recent Pat Drug Deliv Formul; 2015; 9(3):192-3. PubMed ID: 26051151 [No Abstract] [Full Text] [Related]
13. [Strategy and core technologies for the secondary development of Chinese patent medicine]. Zhagn BL; Fan XH; Liu Y; Qu HB; Zhang JH; Chegn YY Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3797-800. PubMed ID: 24558853 [TBL] [Abstract][Full Text] [Related]
14. Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction. Palazzoli F; Bire S; Bigot Y; Bonnin-Rouleux F Nat Biotechnol; 2011 Jul; 29(7):593-7. PubMed ID: 21747382 [No Abstract] [Full Text] [Related]
15. Reach-through claims for drug target patents: Rx for pharmaceutical policy. Bohrer RA Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015 [No Abstract] [Full Text] [Related]
16. The importance of being inventive. Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues. Rutz B; Yeats S EMBO Rep; 2004 Feb; 5(2):119-23. PubMed ID: 14755300 [TBL] [Abstract][Full Text] [Related]
17. Drug delivery applications of supercritical fluid technology. Preface. Kawashima Y; York P Adv Drug Deliv Rev; 2008 Feb; 60(3):297-8. PubMed ID: 18055060 [No Abstract] [Full Text] [Related]
19. The impact of systems approaches on biological problems in drug discovery. Hood L; Perlmutter RM Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453 [No Abstract] [Full Text] [Related]
20. New life for patents. Am Fam Physician; 1981 Jul; 24(1):90. PubMed ID: 7258072 [No Abstract] [Full Text] [Related] [Next] [New Search]